【0】CASE 34

【1】CASE REPORT

【2】A 21-year-old male presented with chief complaints of fever for 1 month, loss of weight,  删除换行1 and loss of appetite. Patient was started on a regimen based on rifampicin, isoniazid,  删除换行1 pyrazinamide, and ethambutol by private practitioner which he took for 7 months but  删除换行1 patient continued to have fever and there was no resolution of chest infiltrates. Patient  删除换行1 was referred to our center in November, 2014. Gene Xpert in December, 2014 detected  删除换行1 rifampicin resistance. His culture sensitivity showed resistance to isoniazid, rifampicin,  删除换行1 pyrazinamide, ethambutol, streptomycin, ciprofloxacin, and was susceptible to kanamycin,  删除换行1 levofloxacin, amikacin, and capreomycin. Patient was put on a regimen for multidrugresistant tuberculosis (MDR-TB) in December, 2014 consisting of kanamycin, ethionamide,  删除换行1 cycloserine, levofloxacin, pyrazinamide, and ethambutol. Kanamycin was stopped at  删除换行1 9  months when sputum smear and culture for Mycobacterium tuberculosis (MTB) became  删除换行1 negative. Rest of the drugs including pyrazinamide were continued for 20 months. It is worth  删除换行1 to note that pyrazinamide were given throughout the treatment. Patient sputum smear  删除换行1 and culture remained negative for MTB. There was significant improvement clinically and  删除换行1 radiologically. Patient remained asymptomatic after 6 months of follow-up after stopping the  删除换行1 treatment 删除33：<u></u>.
DISCUSSION
删除24：<u>Please refer to Case 44 for discussion.</u>
删除3：<u>FIGS. 1A TO F: (A) Chest X-ray posteroanterior (PA) view showing infiltrates in the left upper  删除换行1 zone put on primary line of antitubercular treatment (ATT); (B) Chest X-ray PA view after 6 months  删除换行1 of primary line of ATT without any response and put on multidrug-resistant (MDR) treatment;  删除换行1 (C) Chest X-ray PA view after 56 months of MDR treatment; (D) Chest X-ray PA view after 9 months  删除换行1 of MDR treatment when Kanamycin was stopped; (E) Chest X-ray PA view after 2 years of MDR </u>

【3】treatment when treatment was stopped; and (F) Chest X-ray PA view after 6 months of followup  删除换行1 after stopping MDR treatment.
删除14：<u>D</u>删除14：<u>A B</u>删除14：<u>E</u>删除14：<u>C</u>删除14：<u>F</u>Multidrug-resistant Tuberculosis under 

【4】Treatment with Residual Lesion and 

【5】Adverse Drug Reaction苏锦恭

====================================================================================================
